-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HXc0tLtafAcdcJsvE93JzF/BrNbRPdvXXA26cPp4m88O+tybPnnPbWnT0DGCBLOC P3o+3FcY1P69a8XPdSgTGQ== 0000904454-97-000046.txt : 19970222 0000904454-97-000046.hdr.sgml : 19970222 ACCESSION NUMBER: 0000904454-97-000046 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19970213 SROS: NONE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000890465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870439579 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-44877 FILM NUMBER: 97529974 BUSINESS ADDRESS: STREET 1: 420 CHIPETA WAY SUITE 240 CITY: SALT LAKE CITY STATE: UT ZIP: 84108-1256 BUSINESS PHONE: 8015834939 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BIOTECHNOLOGY INVESTMENTS LTD CENTRAL INDEX KEY: 0000901110 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: ST JULIANS COURT ST PETERS PORT STREET 2: GUERNSEY CITY: CHANNEL ISLANDS STATE: NY ZIP: 00000 SC 13G 1 CUSIP No. 032346108 Page 1 of 6 Pages SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________ SCHEDULE 13G Information Statement pursuant to Rules 13d-1 and 13d-2 Under the Securities Exchange Act of 1934 (Final Amendment) Amylin Pharmaceuticals, Inc. (Name ofIssuer) ___________________________________________________________________ Common Stock, $.001 par value ___________________________________________________________________ (Title of Class of Securities) 032346108 ____________________________________________________________________ (CUSIP Number) ________________________ CUSIP No. 032346108 Page 2 of 6 Pages _________________________________________________________________ 1) Name of Reporting Person Biotechnology S.S. or I.R.S. Identification Investments No. of Above Person Limited _________________________________________________________________ 2) Check the Appropriate Box (a) [ ] if a Member of a Group (b) [ ] _________________________________________________________________ 3) SEC Use Only _________________________________________________________________ 4) Citizenship or Place Guernsey, of Organization Channel Islands _________________________________________________________________ Number of 5) Sole Voting 1,089,269 shares of Shares Beneficially Power Common Stock, $.001 Owned by Each par value ("Common Reporting Person Stock") ________________________________________ 6) Shared Voting Power -0- ________________________________________ 7) Sole Disposi- 1,089,269 shares of tive Power Common Stock ________________________________________ 8) Shared Dis- positive Power -0- ________________________________________ 9) Aggregate Amount Beneficially 1,089,269 shares of Owned by Each Reporting Person Common Stock _________________________________________________________________ 10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares _________________________________________________________________ 11) Percent of Class Represented by 3.4% Amount in Row (9) _________________________________________________________________ 12) Type of Reporting Person CO CUSIP No. 032346108 Page 3 of 6 Pages Final Amendment to Schedule 13G _______________________________ Reference is hereby made to the statement on Schedule 13G originally filed with the Securities and Exchange Commission on February 16, 1993, as amended by Amendment No. 1 thereto filed on February 14, 1995 and Amendment No. 2 thereto filed on February 9, 1996. Item 1(a) - Name of Issuer: Amylin Pharmaceuticals, Inc. Item 1(b) - Address of Issuer's Principal Executive Offices: 9373 Towne Centre Drive, Suite 250 San Diego, CA 92121 Item 2(a) - Name of Person Filing: This statement is being filed on behalf of Biotechnology Investments Limited ("BIL" or the "Reporting Person"). BIL is a Guernsey, Channel Islands corporation. Item 2(b) - Address of Principal Business Office: P.O. Box 58 St. Julian's Court St. Peter Port Guernsey, Channel Islands GYI 3BP Item 2(c) - Place of Organization: Guernsey, Channel Islands Item 2(d) - Title of Class of Securities: Common Stock, $.001 par value ("Common Stock") Item 2(e) - CUSIP Number: 032346108 Item 3 - Statements Filed Pursuant to Rules 13d-1(b) or 13d-2(b): Not applicable. Item 4 - Ownership. (a) Amount Beneficially Owned: 1,089,269 shares of Common Stock CUSIP No. 032346108 Page 4 of 6 Pages (b) Percent of Class: 3.4% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 1,089,269 shares (ii) shared power to vote or to direct the vote: -0- (iii) sole power to dispose or to direct the disposition of: 1,089,269 shares (iv) shared power to dispose or to direct the disposition of: -0- Item 5 - Ownership of Five Percent or Less of a Class: This statement is being filed to report that as of the date hereof the Reporting Person has ceased to be the beneficial owner of more than five percent of the Common Stock. Item 6 - Ownership of More than Five Percent on Behalf of Another Person: Not applicable. CUSIP No. 032346108 Page 5 of 6 Pages Item 7 - Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Company: Not applicable. Item 8 - Identification and Classification of Members of the Group: Not applicable. Item 9 - Notice of Dissolution of Group: Not applicable. Item 10 - Certification: Not applicable. CUSIP No. 032346108 Page 5 of 6 Pages Signature: After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. BIOTECHNOLOGY INVESTMENTS LIMITED By: Old Court Limited _________________________________ By /s/ Kathleen K. Schoemaker Attorney-in-Fact Date: February 12, 1997 CUSIP No. 032346108 Page 6 of 6 Pages OLD COURT LIMITED P.O. Box 58, St. Julian's Court, St. Peter Port, Guernsey, Channel Islands GYI 3BP Our Ref: PF/domain/POA174 12 February 1997 Domain Associates One Palmer Square Princeton, New Jersey 08542 USA Dear Sirs Biotechnology Investments Limited We, Old Court Limited hereby authorise you to execute on behalf of Old Court Limited a Schedule 13G to be filed with the Securities and Exchange Commission regarding Biotechnology Investments Limited's holdings of Amylin Pharmaceuticals, Inc. Yours very truly per pro Old Court Limited /s/ S.H. Down /s/ S.E. Shaw __________________________ __________________________ S.H. Down, Director S.E. Shaw, Director We confirm that we have authorised Old Court Limited to grant the above Power of Attorney. Yours very truly per pro Biotechnology Investments Limited ___________________________________ /s/ P.A.S. Firth P.A.S. Firth, Authorised Signatory -----END PRIVACY-ENHANCED MESSAGE-----